Pricing

Chiasma

1 follower

‌

Chiasma is a late-stage biopharmaceutical company focused on improving the lives of patients suffering from orphan diseases by developing and commercializing novel oral forms of therapies that are available today only by injection.

Industries

Biotechnology

Headquarters

Waltham, United States

Employees

11-50

Links

Org chart

Raj Kannan

Chief Executive Officer

Raj Kannan

Collapse

Asi Haviv

VP Clinical Development

Dan Thornton

VP Market Access and Patient Services

David Plante

VP Information Technology

Dawn Schottlandt

VP Investor Relations & Corporate Communications

Derek Brown

VP Marketing

Drew Enamait

VP Finance & Administration

Ethel Koczon

VP Clinical Operations

Gary Patou

Head of Clinical

Joe Lyons

Executive Director Human Resources

VP General Counsel

President

VP Medical Affairs

VP Quality Assurance & Regulatory Affairs

William Ludlam

Senior VP Clinical Development and Medical Affairs

Teams

+10

Leadership Team

13 members

Clinical Operations

6 members

Human Resources and Administration

3 members

Similar companies

Thermo Fisher Scientific

156 followers

GRAIL

27 followers

Cytokinetics

11 followers

Caris Life Sciences

2 followers

BridgeBio

2 followers

Tessera Therapeutics

2 followers

Immunome

2 followers

Entrada Therapeutics

1 follower

Scholar Rock

1 follower

Anthropic

51 followers

Mineralys Therapeutics

1 follower

Explore companies